Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

US Stem Cell (USRM)

US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

US Stem Cell 1560 SAWGRASS CORPORATE PKWY 4TH FLOOR SUNRISE FL 33323 USA

www.us-stemcell.com P: 954-835-1500

Description:

U.S. Stem cell, Inc. is engaged in the regenerative medicine / cellular therapy industry. The company focused on the discovery, development and commercialization of cell based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function. Its operating division consists of US Stem Cell Training, Vetbiologics and US Stem Cell Clinic. US Stem Cell, Inc., formerly known as Bioheart, Inc., is headquartered in Sunrise, Florida.

Key Statistics

Overview:

Market Capitalization, $K 66
Enterprise Value, $K 2,136
Shares Outstanding, K 661,507
Annual Sales, $ 80 K
Annual Net Income, $ -2,860 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -570 K
EBIT, $ -1,330 K
EBITDA, $ -640 K
% of Insider Shareholders 16.72%
% of Institutional Shareholders 0.00%
Float, K 550,903
% Float 83.28%
Short Volume Ratio 0.95

Growth:

1-Year Return 0.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -98.55%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 01/03/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

USRM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -3,575.00%
Debt/Equity -0.14
Price/Sales 0.94
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.02
Interest Coverage -3.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar